Current Neurovascular Research
Title:Circadian Clock Genes: Targeting Innate Immunity for Antiviral Strategies Against COVID-19
Volume: 17 Issue: 5
Author(s): Kenneth Maiese
Affiliation:
Export Options
About this article
Cite this article as:
Maiese Kenneth , Circadian Clock Genes: Targeting Innate Immunity for Antiviral Strategies Against COVID-19, Current Neurovascular Research 2020; 17 (5) . https://dx.doi.org/10.2174/1567202617666201203110008
DOI https://dx.doi.org/10.2174/1567202617666201203110008 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Covid-19: An Update on Clinical Features, Diagnosis, and Treatment Strategies
Coronaviruses Efficacy of Dexamethasone for the Treatment of COVID-19 Infection: A Perspective Review
Current Drug Delivery Novel Coronavirus Disease and the Current Scenario of the Global Health Emergency
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Predict Drug-Protein Interaction in Cellular Networking
Current Topics in Medicinal Chemistry Impacts and Consequences of COVID-19 Epidemic on Global Economy
Coronaviruses COVID-19 Pandemic: How can Computer-assisted Methods help to Rein in this Global Menace?
Current Computer-Aided Drug Design C1-Inhibitor: Structure, Functional Diversity and Therapeutic Development
Current Medicinal Chemistry Combined Virtual Screening Strategies
Current Computer-Aided Drug Design Prothymosin α and its C-Terminal Immunoreactive Decapeptide Show No Evidence of Acute Toxicity: A Preliminary <i>In Silico</i>, <i>In Vitro</i> and <i>In Vivo</i> Investigation
Current Medicinal Chemistry The Potential Mechanism of N-acetylcysteine in Treating COVID-19
Current Pharmaceutical Biotechnology Adapting Gravity Model for Predicting the Risk of COVID -19 in Nigeria
Coronaviruses Recent Advances Towards Drug Design Targeting the Protease of 2019 Novel Coronavirus (2019-nCoV)
Current Medicinal Chemistry Molecular Descriptors of Some Chemicals that Prevent COVID-19
Current Organic Synthesis How India Fights with COVID-19 Learning from Highly Affected Countries
Current Signal Transduction Therapy Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight
Current Pharmaceutical Biotechnology From Vancomycin to Oritavancin: The Discovery and Development of a Novel Lipoglycopeptide Antibiotic
Anti-Infective Agents in Medicinal Chemistry An Augmented Passive Immune Therapy to Treat Fulminant Bacterial Infections
Recent Patents on Anti-Infective Drug Discovery ACE2 as a Potential Target for Management of Novel Coronavirus (nCoV- 2019)
Current Drug Discovery Technologies Adverse Reactions and Pathogen Safety of Intravenous Immunoglobulin
Current Drug Safety Machine Learning in Discovery of New Antivirals and Optimization of Viral Infections Therapy
Current Medicinal Chemistry